blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3119413

EP3119413 - SUBLINGUAL DELIVERY OF GLATIRAMER ACETATE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.03.2022
Database last updated on 26.07.2024
FormerThe patent has been granted
Status updated on  09.04.2021
FormerGrant of patent is intended
Status updated on  23.11.2020
FormerExamination is in progress
Status updated on  27.07.2019
FormerRequest for examination was made
Status updated on  23.12.2016
FormerThe international publication has been made
Status updated on  28.11.2016
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Mapi Pharma Limited
16 Einstein Street Weizmann Science Park P.O. Box 4113
74140 Ness Ziona / IL
[2021/19]
Former [2017/04]For all designated states
Mapi Pharma Limited
16 Einstein Street Weizmann Science Park P.O. Box 4113
74140 Ness Ziona / IL
Inventor(s)01 / SELA, Yoram
3 Hadas Street
43263 Ra'anana / IL
02 / MAROM, Ehud
7 Aluf Kalman Magen Street
6107079, Tel Aviv / IL
03 / BLEICH KIMELMAN, Nadav
30 HaRav Berlin Street
92503 Jerusalem / IL
 [2017/04]
Representative(s)Straus, Alexander, et al
2K Patent- und Rechtsanwälte - München
Keltenring 9
82041 Oberhaching / DE
[2021/19]
Former [2017/04]Becker Kurig Straus
Patentanwälte
Bavariastrasse 7
80336 München / DE
Application number, filing date15764661.316.03.2015
[2017/04]
WO2015IL50275
Priority number, dateUS201461953945P17.03.2014         Original published format: US 201461953945 P
[2017/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015140790
Date:24.09.2015
Language:EN
[2015/38]
Type: A1 Application with search report 
No.:EP3119413
Date:25.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 24.09.2015 takes the place of the publication of the European patent application.
[2017/04]
Type: B1 Patent specification 
No.:EP3119413
Date:12.05.2021
Language:EN
[2021/19]
Search report(s)International search report - published on:IL24.09.2015
(Supplementary) European search report - dispatched on:EP09.08.2017
ClassificationIPC:A61K38/03, A61K47/00, A61K9/00, A61P37/00, A61K47/10, A61K9/20
[2020/49]
CPC:
A61K38/03 (EP,US); A61K47/10 (EP,US); A61K9/006 (EP,US);
A61K9/12 (US); A61K9/2013 (US); A61K9/2018 (EP,US);
A61K9/2027 (US); A61K9/2059 (US); A61P37/00 (EP) (-)
Former IPC [2017/04]A61K38/03, A61K47/00, A61K9/00, A61P37/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/04]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:SUBLINGUALE VERABREICHUNG VON GLATIRAMERACETAT[2017/04]
English:SUBLINGUAL DELIVERY OF GLATIRAMER ACETATE[2017/04]
French:ADMINISTRATION SUBLINGUALE D'ACÉTATE DE GLATIRAMÈRE[2017/04]
Entry into regional phase20.09.2016National basic fee paid 
20.09.2016Search fee paid 
20.09.2016Designation fee(s) paid 
20.09.2016Examination fee paid 
Examination procedure20.09.2016Examination requested  [2017/04]
20.09.2016Date on which the examining division has become responsible
28.02.2018Amendment by applicant (claims and/or description)
31.07.2019Despatch of a communication from the examining division (Time limit: M06)
27.01.2020Reply to a communication from the examining division
24.11.2020Communication of intention to grant the patent
01.04.2021Fee for grant paid
01.04.2021Fee for publishing/printing paid
01.04.2021Receipt of the translation of the claim(s)
Opposition(s)15.02.2022No opposition filed within time limit [2022/16]
Fees paidRenewal fee
11.01.2017Renewal fee patent year 03
31.01.2018Renewal fee patent year 04
22.01.2019Renewal fee patent year 05
17.01.2020Renewal fee patent year 06
28.01.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.03.2015
AL12.05.2021
AT12.05.2021
CY12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
IT12.05.2021
LT12.05.2021
LV12.05.2021
MC12.05.2021
MK12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SI12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
[2024/22]
Former [2024/20]HU16.03.2015
AL12.05.2021
AT12.05.2021
CY12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
IT12.05.2021
LT12.05.2021
LV12.05.2021
MC12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SI12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2024/18]HU16.03.2015
AL12.05.2021
AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
IT12.05.2021
LT12.05.2021
LV12.05.2021
MC12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SI12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/47]AL12.05.2021
AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
IT12.05.2021
LT12.05.2021
LV12.05.2021
MC12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SI12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/36]AL12.05.2021
AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
IT12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SI12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/29]AL12.05.2021
AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SI12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/26]AL12.05.2021
AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/23]AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/10]AT12.05.2021
CZ12.05.2021
DK12.05.2021
EE12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
PT13.09.2021
IS22.12.2021
Former [2022/09]AT12.05.2021
CZ12.05.2021
DK12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RO12.05.2021
RS12.05.2021
SE12.05.2021
SK12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/08]AT12.05.2021
CZ12.05.2021
DK12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RS12.05.2021
SE12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/07]AT12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RS12.05.2021
SE12.05.2021
SM12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2022/04]AT12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
NL12.05.2021
PL12.05.2021
RS12.05.2021
SE12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2021/52]AT12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
PL12.05.2021
RS12.05.2021
SE12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2021/51]AT12.05.2021
ES12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
RS12.05.2021
SE12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
IS12.09.2021
PT13.09.2021
Former [2021/50]AT12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
SE12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
PT13.09.2021
Former [2021/49]AT12.05.2021
FI12.05.2021
HR12.05.2021
LT12.05.2021
LV12.05.2021
SE12.05.2021
BG12.08.2021
NO12.08.2021
GR13.08.2021
Former [2021/47]AT12.05.2021
FI12.05.2021
LT12.05.2021
BG12.08.2021
Former [2021/46]AT12.05.2021
FI12.05.2021
LT12.05.2021
Documents cited:Search[XI]WO2006004749  (ID BIOMEDICAL CORP QUEBEC [CA], et al) [X] 1,3,8,11,15 * page 23, paragraph last - page 24, line 24; claims 1,2,4,18,23 * * page 12 - page 15 * [I] 1-15;
 [X]WO2008120207  (YISSUM RES DEV CO [IL], et al) [X] 1,2,7,8,11,12,15 * page 8, paragraph 2; examples 8,13-19; claims 1,5,8 * * page 9, paragraph 4 * * page 7, paragraph 3 *;
 [XI]WO2010011879  (UNIV JOHNS HOPKINS [US], et al) [X] 1-3,8,11,12,15 * paragraphs [0036] , [0044] , [0045]; claims 2,28,36-38 * [I] 1-15;
 [XI]WO2010032140  (CHIASMA INC [US], et al) [X] 1,3,4,7,8,11,15 * page 31, line 19 - line 21; claims 1, 16, 153 * * page 5, line 28 - line 30 * [I] 1-15;
 [X]US2012263764  (WATSON RICHARD L [US]) [X] 1,3,8,11,15* paragraphs [0229] , [0231] , [0233] , [0256]; claims 1,29 *
International search[Y]US2001055568  (GILBERT ADRIAN [IL], et al) [Y] 19-21 * para. 0037, 0041-0042, 0044 *;
 [X]US2005170004  (ROSENBERGER VERED [IL], et al) [X] 1, 2, 25-27, 29-31 * abstract; para. 47, 60; examples 3-4 *;
 [Y]US2005214251  (POHL RODERIKE [US], et al) [Y] 1-40 * whole document *;
 [Y]US2007065492  (BODOR NICHOLAS S [US]) [Y] 17, 18* abstract; claim 28 *;
 [Y]US2009053176  (AHLBERG GABRIELLE [SE], et al) [Y] 1-40 * abstract; para. 0014, 0019, 0206, 0214, 0220-0221, 0225, 0228, 0232, 0238 *;
 [PY]WO2014100639  (TEVA PHARMA [IL], et al) [PY] 1-40 * p. 6-7; examples *;
 [PY]WO2014100643  (TEVA PHARMA [IL], et al) [PY] 1-40 * p. 6-7; examples *
by applicantWO2014100639
    - MOINGEON PBATARD TFADEL RFRATI FSIEBER JVAN OVERTVELT L, "Immune mechanisms of allergen-specific sublingual immunotherapy", Allergy, (20060000), vol. 61, no. 2, doi:10.1111/j.1398-9995.2006.01002.x, pages 151 - 65, XP055243892

DOI:   http://dx.doi.org/10.1111/j.1398-9995.2006.01002.x
    - Neurology, (19980505), vol. 0, no. 5, pages 1273 - 81
    - L. GUO, "Evaluation of a Rat Model of Experimental Autoimmune Encephalomyelitis with Human MBP as Antigen", Cellular & Molecular Immunology, (20040000), vol. 1, no. 5, pages 387 - 391
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.